Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by aussyspitzon May 31, 2020 3:24pm
242 Views
Post# 31093968

Liminal Translate

Liminal TranslateEnter You Text From Liminal Here:

Liminal BioSciences is scheduled to present a company overview at Jefferies Virtual Healthcare Conference on Thursday 4th June at 14:30

Translated Text As Follows:

Desperate for a Partner Liminal BioSciences aka the ugliest girl in the biotech industry plans to put on some cheap perfume, a short dress, fishnet stockings, lipstick and high heels and stand on the corner at the Jeffries Virtual Healthcare Conference on Thursday 4th June 2020 hoping to get lucky .
<< Previous
Bullboard Posts
Next >>